Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thorough QT/QTc Study of Staccato® Prochlorperazine for Inhalation in Healthy Volunteers

NCT00543062 is registered in ClinicalTrials.gov with Alexza Pharmaceuticals, Inc. as lead sponsor.

NCT NCT00543062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00543062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thorough QT/QTc Study of Staccato® Prochlorperazine for Inhalation in Healthy Volunteers
Lead sponsor
Alexza Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2007
Completion date
December 31, 2007
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity